Not checked for notices yet.

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

Annika Nelde, Daniel J. Kowalewski, Linus Backert and 9 more

OncoImmunology · 2018

doi:10.1080/2162402x.2017.1316438

Cited by papers we hold 1

The Peptide Vaccine of the Future · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.